Literature DB >> 7658208

Delineation of myocardial viability with PET.

C Grandin1, W Wijns, J A Melin, A Bol, A R Robert, G R Heyndrickx, C Michel, J L Vanoverschelde.   

Abstract

UNLABELLED: Relative flow and metabolic imaging (the "mismatch pattern") with PET have been proposed to identify the presence of viable myocardium in patients with ischemic left ventricular dysfunction. Yet, optimal criteria to identify dysfunctional but viable myocardium and predict significant functional improvement have not been fully defined.
METHODS: Dynamic PET imaging with 13N-ammonia and 18F-deoxyglucose to assess absolute myocardial perfusion and glucose uptake was performed in 25 patients (20 men, 5 women; mean age 57 +/- 12 yr, range 30-72 yr) scheduled for coronary revascularization because of coronary artery disease, anterior wall dysfunction and mildly depressed left ventricular ejection fraction (49% +/- 11%). Global and regional left ventricular function was evaluated by contrast left ventriculography at baseline and after revascularization.
RESULTS: As judged from the changes in end-systolic volume and resting anterior wall motion before and after revascularization, 17 patients with improved wall motion score and decreased end-systolic volume were considered to have viable myocardium, whereas 8 patients with either no change in regional wall motion or increased end-systolic volume were considered to have nonviable myocardium. Before revascularization, viable myocardium showed higher absolute myocardial blood flow (77 +/- 20 versus 51 +/- 9 ml (min.100 g)-1, p = 0.004) and absolute regional myocardial glucose uptake (36 +/- 14 versus 24 +/- 11 mumole (min.100 g)-1, p = 0.04) than nonviable myocardium.
CONCLUSION: This study identified absolute myocardial blood flow and normalized glucose extraction as the most powerful predictors of the return of contractile function after coronary revascularization in patients with ischemic anterior wall dysfunction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7658208

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  14 in total

Review 1.  Pathophysiology of myocardial hibernation. Implications for the use of dobutamine echocardiography to identify myocardial viability.

Authors:  J L Vanoverschelde; A Pasquet; B Gerber; J A Melin
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

Review 2.  Hibernating myocardium.

Authors:  R Schulz; G Heusch
Journal:  Heart       Date:  2000-12       Impact factor: 5.994

3.  Assessment of myocardial viability: more than measurements of radiotracer uptake alone.

Authors:  James A Arrighi
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

4.  Myocardial viability: seeking relevance and redefinition.

Authors:  J A Arrighi; R Soufer
Journal:  J Nucl Cardiol       Date:  1998 Nov-Dec       Impact factor: 5.952

Review 5.  What is the current status of quantification and nuclear medicine in cardiology?

Authors:  G Hör
Journal:  Eur J Nucl Med       Date:  1996-07

6.  Effects of coronary revascularisation on myocardial blood flow and coronary vasodilator reserve in hibernating myocardium.

Authors:  D Pagano; F Fath-Ordoubadi; K J Beatt; J N Townend; R S Bonser; P G Camici
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

Review 7.  [Examination of myocardial perfusion with positron emission tomography: a clinically useful and valid method?].

Authors:  J vom Dahl
Journal:  Herz       Date:  1997-02       Impact factor: 1.443

8.  Coronary blood flow, metabolism, and function in dysfunctional viable myocardium before and early after surgical revascularisation.

Authors:  F Alamanni; A Parolari; A Repossini; E Doria; F Bortone; J Campolo; M Pepi; E Sisillo; M Naliato; R Bigi; P Biglioli; O Parodi
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

9.  Direct comparison between 2-dimensional and 3-dimensional PET acquisition modes for myocardial blood flow absolute quantification with O-15 water and N-13 ammonia.

Authors:  Véronique Roelants; Anne Bol; Xavier Bernard; Ann Coppens; Jacques Melin; Bernhard Gerber; Jean-Louis Vanoverschelde
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

Review 10.  Hibernation and congestive heart failure.

Authors:  David P Dutka; Paolo G Camici
Journal:  Heart Fail Rev       Date:  2003-04       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.